1. Home
  2. OLPX vs CTMX Comparison

OLPX vs CTMX Comparison

Compare OLPX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olaplex Holdings Inc.

OLPX

Olaplex Holdings Inc.

HOLD

Current Price

$2.04

Market Cap

1.0B

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.56

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLPX
CTMX
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
977.1M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
OLPX
CTMX
Price
$2.04
$3.56
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$1.89
$12.10
AVG Volume (30 Days)
3.1M
2.9M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,960,000.00
$76,201,000.00
Revenue This Year
$2.95
N/A
Revenue Next Year
$3.39
$7.61
P/E Ratio
N/A
$22.58
Revenue Growth
0.07
N/A
52 Week Low
$0.99
$1.72
52 Week High
$2.06
$8.21

Technical Indicators

Market Signals
Indicator
OLPX
CTMX
Relative Strength Index (RSI) 61.82 36.09
Support Level $2.02 $3.40
Resistance Level N/A $3.91
Average True Range (ATR) 0.01 0.18
MACD -0.01 0.01
Stochastic Oscillator 50.00 21.58

Price Performance

Historical Comparison
OLPX
CTMX

About OLPX Olaplex Holdings Inc.

Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: